Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Myasthenia Gravis Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Drug Treatment
1.2.3 Rapid Immunotherapies
1.3 Market by Application
1.3.1 Global Myasthenia Gravis Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Myasthenia Gravis Market Perspective (2018-2033)
2.2 Myasthenia Gravis Growth Trends by Region
2.2.1 Global Myasthenia Gravis Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Myasthenia Gravis Historic Market Size by Region (2018-2023)
2.2.3 Myasthenia Gravis Forecasted Market Size by Region (2024-2033)
2.3 Myasthenia Gravis Market Dynamics
2.3.1 Myasthenia Gravis Industry Trends
2.3.2 Myasthenia Gravis Market Drivers
2.3.3 Myasthenia Gravis Market Challenges
2.3.4 Myasthenia Gravis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Myasthenia Gravis Players by Revenue
3.1.1 Global Top Myasthenia Gravis Players by Revenue (2018-2023)
3.1.2 Global Myasthenia Gravis Revenue Market Share by Players (2018-2023)
3.2 Global Myasthenia Gravis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Myasthenia Gravis Revenue
3.4 Global Myasthenia Gravis Market Concentration Ratio
3.4.1 Global Myasthenia Gravis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Myasthenia Gravis Revenue in 2022
3.5 Myasthenia Gravis Key Players Head office and Area Served
3.6 Key Players Myasthenia Gravis Product Solution and Service
3.7 Date of Enter into Myasthenia Gravis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Myasthenia Gravis Breakdown Data by Type
4.1 Global Myasthenia Gravis Historic Market Size by Type (2018-2023)
4.2 Global Myasthenia Gravis Forecasted Market Size by Type (2024-2033)
5 Myasthenia Gravis Breakdown Data by Application
5.1 Global Myasthenia Gravis Historic Market Size by Application (2018-2023)
5.2 Global Myasthenia Gravis Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Myasthenia Gravis Market Size (2018-2033)
6.2 North America Myasthenia Gravis Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Myasthenia Gravis Market Size by Country (2018-2023)
6.4 North America Myasthenia Gravis Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Myasthenia Gravis Market Size (2018-2033)
7.2 Europe Myasthenia Gravis Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Myasthenia Gravis Market Size by Country (2018-2023)
7.4 Europe Myasthenia Gravis Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Myasthenia Gravis Market Size (2018-2033)
8.2 Asia-Pacific Myasthenia Gravis Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Myasthenia Gravis Market Size by Region (2018-2023)
8.4 Asia-Pacific Myasthenia Gravis Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Myasthenia Gravis Market Size (2018-2033)
9.2 Latin America Myasthenia Gravis Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Myasthenia Gravis Market Size by Country (2018-2023)
9.4 Latin America Myasthenia Gravis Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Myasthenia Gravis Market Size (2018-2033)
10.2 Middle East & Africa Myasthenia Gravis Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Myasthenia Gravis Market Size by Country (2018-2023)
10.4 Middle East & Africa Myasthenia Gravis Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Detail
11.1.2 Takeda Business Overview
11.1.3 Takeda Myasthenia Gravis Introduction
11.1.4 Takeda Revenue in Myasthenia Gravis Business (2018-2023)
11.1.5 Takeda Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Detail
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Myasthenia Gravis Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Myasthenia Gravis Business (2018-2023)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 CSL Behring
11.3.1 CSL Behring Company Detail
11.3.2 CSL Behring Business Overview
11.3.3 CSL Behring Myasthenia Gravis Introduction
11.3.4 CSL Behring Revenue in Myasthenia Gravis Business (2018-2023)
11.3.5 CSL Behring Recent Development
11.4 Grifols
11.4.1 Grifols Company Detail
11.4.2 Grifols Business Overview
11.4.3 Grifols Myasthenia Gravis Introduction
11.4.4 Grifols Revenue in Myasthenia Gravis Business (2018-2023)
11.4.5 Grifols Recent Development
11.5 Alexion Pharmaceutical
11.5.1 Alexion Pharmaceutical Company Detail
11.5.2 Alexion Pharmaceutical Business Overview
11.5.3 Alexion Pharmaceutical Myasthenia Gravis Introduction
11.5.4 Alexion Pharmaceutical Revenue in Myasthenia Gravis Business (2018-2023)
11.5.5 Alexion Pharmaceutical Recent Development
11.6 Avadel Pharmaceuticals
11.6.1 Avadel Pharmaceuticals Company Detail
11.6.2 Avadel Pharmaceuticals Business Overview
11.6.3 Avadel Pharmaceuticals Myasthenia Gravis Introduction
11.6.4 Avadel Pharmaceuticals Revenue in Myasthenia Gravis Business (2018-2023)
11.6.5 Avadel Pharmaceuticals Recent Development
11.7 Baxter International
11.7.1 Baxter International Company Detail
11.7.2 Baxter International Business Overview
11.7.3 Baxter International Myasthenia Gravis Introduction
11.7.4 Baxter International Revenue in Myasthenia Gravis Business (2018-2023)
11.7.5 Baxter International Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Myasthenia Gravis Introduction
11.8.4 Novartis Revenue in Myasthenia Gravis Business (2018-2023)
11.8.5 Novartis Recent Development
11.9 Bausch Health
11.9.1 Bausch Health Company Detail
11.9.2 Bausch Health Business Overview
11.9.3 Bausch Health Myasthenia Gravis Introduction
11.9.4 Bausch Health Revenue in Myasthenia Gravis Business (2018-2023)
11.9.5 Bausch Health Recent Development
11.10 Takeda Pharmaceutical Company
11.10.1 Takeda Pharmaceutical Company Company Detail
11.10.2 Takeda Pharmaceutical Company Business Overview
11.10.3 Takeda Pharmaceutical Company Myasthenia Gravis Introduction
11.10.4 Takeda Pharmaceutical Company Revenue in Myasthenia Gravis Business (2018-2023)
11.10.5 Takeda Pharmaceutical Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Myasthenia Gravis Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Drug Treatment
Table 3. Key Players of Rapid Immunotherapies
Table 4. Global Myasthenia Gravis Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Myasthenia Gravis Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Myasthenia Gravis Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Myasthenia Gravis Market Share by Region (2018-2023)
Table 8. Global Myasthenia Gravis Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Myasthenia Gravis Market Share by Region (2024-2033)
Table 10. Myasthenia Gravis Market Trends
Table 11. Myasthenia Gravis Market Drivers
Table 12. Myasthenia Gravis Market Challenges
Table 13. Myasthenia Gravis Market Restraints
Table 14. Global Myasthenia Gravis Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Myasthenia Gravis Market Share by Players (2018-2023)
Table 16. Global Top Myasthenia Gravis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis as of 2022)
Table 17. Ranking of Global Top Myasthenia Gravis Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Myasthenia Gravis Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Myasthenia Gravis Product Solution and Service
Table 21. Date of Enter into Myasthenia Gravis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Myasthenia Gravis Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Myasthenia Gravis Revenue Market Share by Type (2018-2023)
Table 25. Global Myasthenia Gravis Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Myasthenia Gravis Revenue Market Share by Type (2024-2033)
Table 27. Global Myasthenia Gravis Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Myasthenia Gravis Revenue Market Share by Application (2018-2023)
Table 29. Global Myasthenia Gravis Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Myasthenia Gravis Revenue Market Share by Application (2024-2033)
Table 31. North America Myasthenia Gravis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Myasthenia Gravis Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Myasthenia Gravis Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Myasthenia Gravis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Myasthenia Gravis Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Myasthenia Gravis Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Myasthenia Gravis Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Myasthenia Gravis Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Myasthenia Gravis Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Myasthenia Gravis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Myasthenia Gravis Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Myasthenia Gravis Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Myasthenia Gravis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Myasthenia Gravis Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Myasthenia Gravis Market Size by Country (2024-2033) & (US$ Million)
Table 46. Takeda Company Detail
Table 47. Takeda Business Overview
Table 48. Takeda Myasthenia Gravis Product
Table 49. Takeda Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)
Table 50. Takeda Recent Development
Table 51. F. Hoffmann-La Roche Company Detail
Table 52. F. Hoffmann-La Roche Business Overview
Table 53. F. Hoffmann-La Roche Myasthenia Gravis Product
Table 54. F. Hoffmann-La Roche Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)
Table 55. F. Hoffmann-La Roche Recent Development
Table 56. CSL Behring Company Detail
Table 57. CSL Behring Business Overview
Table 58. CSL Behring Myasthenia Gravis Product
Table 59. CSL Behring Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)
Table 60. CSL Behring Recent Development
Table 61. Grifols Company Detail
Table 62. Grifols Business Overview
Table 63. Grifols Myasthenia Gravis Product
Table 64. Grifols Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)
Table 65. Grifols Recent Development
Table 66. Alexion Pharmaceutical Company Detail
Table 67. Alexion Pharmaceutical Business Overview
Table 68. Alexion Pharmaceutical Myasthenia Gravis Product
Table 69. Alexion Pharmaceutical Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)
Table 70. Alexion Pharmaceutical Recent Development
Table 71. Avadel Pharmaceuticals Company Detail
Table 72. Avadel Pharmaceuticals Business Overview
Table 73. Avadel Pharmaceuticals Myasthenia Gravis Product
Table 74. Avadel Pharmaceuticals Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)
Table 75. Avadel Pharmaceuticals Recent Development
Table 76. Baxter International Company Detail
Table 77. Baxter International Business Overview
Table 78. Baxter International Myasthenia Gravis Product
Table 79. Baxter International Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)
Table 80. Baxter International Recent Development
Table 81. Novartis Company Detail
Table 82. Novartis Business Overview
Table 83. Novartis Myasthenia Gravis Product
Table 84. Novartis Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. Bausch Health Company Detail
Table 87. Bausch Health Business Overview
Table 88. Bausch Health Myasthenia Gravis Product
Table 89. Bausch Health Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)
Table 90. Bausch Health Recent Development
Table 91. Takeda Pharmaceutical Company Company Detail
Table 92. Takeda Pharmaceutical Company Business Overview
Table 93. Takeda Pharmaceutical Company Myasthenia Gravis Product
Table 94. Takeda Pharmaceutical Company Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)
Table 95. Takeda Pharmaceutical Company Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Myasthenia Gravis Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Myasthenia Gravis Market Share by Type: 2022 VS 2033
Figure 3. Drug Treatment Features
Figure 4. Rapid Immunotherapies Features
Figure 5. Global Myasthenia Gravis Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Myasthenia Gravis Market Share by Application: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Other Case Studies
Figure 10. Myasthenia Gravis Report Years Considered
Figure 11. Global Myasthenia Gravis Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Myasthenia Gravis Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Myasthenia Gravis Market Share by Region: 2022 VS 2033
Figure 14. Global Myasthenia Gravis Market Share by Players in 2022
Figure 15. Global Top Myasthenia Gravis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Myasthenia Gravis Revenue in 2022
Figure 17. North America Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Myasthenia Gravis Market Share by Country (2018-2033)
Figure 19. United States Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Myasthenia Gravis Market Share by Country (2018-2033)
Figure 23. Germany Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Myasthenia Gravis Market Share by Region (2018-2033)
Figure 31. China Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Myasthenia Gravis Market Share by Country (2018-2033)
Figure 39. Mexico Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Myasthenia Gravis Market Share by Country (2018-2033)
Figure 43. Turkey Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Myasthenia Gravis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Takeda Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)
Figure 46. F. Hoffmann-La Roche Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)
Figure 47. CSL Behring Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)
Figure 48. Grifols Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)
Figure 49. Alexion Pharmaceutical Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)
Figure 50. Avadel Pharmaceuticals Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)
Figure 51. Baxter International Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)
Figure 52. Novartis Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)
Figure 53. Bausch Health Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)
Figure 54. Takeda Pharmaceutical Company Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed